Literature DB >> 11114383

Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

B Oppmann1, R Lesley, B Blom, J C Timans, Y Xu, B Hunte, F Vega, N Yu, J Wang, K Singh, F Zonin, E Vaisberg, T Churakova, M Liu, D Gorman, J Wagner, S Zurawski, Y Liu, J S Abrams, K W Moore, D Rennick, R de Waal-Malefyt, C Hannum, J F Bazan, R A Kastelein.   

Abstract

A novel sequence discovered in a computational screen appears distantly related to the p35 subunit of IL-12. This factor, which we term p19, shows no biological activity by itself; instead, it combines with the p40 subunit of IL-12 to form a novel, biologically active, composite cytokine, which we term IL-23. Activated dendritic cells secrete detectable levels of this complex. IL-23 binds to IL-12R beta 1 but fails to engage IL-12R beta 2; nonetheless, IL-23 activates Stat4 in PHA blast T cells. IL-23 induces strong proliferation of mouse memory (CD4(+)CD45Rb(low)) T cells, a unique activity of IL-23 as IL-12 has no effect on this cell population. Similar to IL-12, human IL-23 stimulates IFN-gamma production and proliferation in PHA blast T cells, as well as in CD45RO (memory) T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11114383     DOI: 10.1016/s1074-7613(00)00070-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  866 in total

1.  Interleukin 12 in part regulates gamma interferon release in human whole blood stimulated with Leptospira interrogans.

Authors:  Maaike de Fost; Rudy A Hartskeerl; Martijn R Groenendijk; Tom van der Poll
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

2.  Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection.

Authors:  Kyle I Happel; Mingquan Zheng; Erana Young; Lee J Quinton; Euan Lockhart; Alistair J Ramsay; Judd E Shellito; Jill R Schurr; Gregory J Bagby; Steve Nelson; Jay K Kolls
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

Review 3.  Unmet Needs in Axial Spondyloarthritis.

Authors:  Ennio Lubrano; Antonia De Socio; Fabio Massimo Perrotta
Journal:  Clin Rev Allergy Immunol       Date:  2018-12       Impact factor: 8.667

4.  A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production.

Authors:  Amy N Sieve; Karen D Meeks; Suheung Lee; Rance E Berg
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

Review 5.  Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity.

Authors:  Peter J Morrison; Sarah J Ballantyne; Marika C Kullberg
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

6.  Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis.

Authors:  Luiz Felipe Domingues Passero; Ana Kely Carvalho; Maria Luiza A C Bordon; Alexis Bonfim-Melo; Marcos Hikari Toyama; Carlos Eduardo Pereira Corbett; Márcia Dalastra Laurenti
Journal:  Inflamm Res       Date:  2011-12-14       Impact factor: 4.575

7.  Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection.

Authors:  Asher Maroof; Paul M Kaye
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

Review 8.  A tale of two cytokines: IL-17 and IL-22 in asthma and infection.

Authors:  Michelle L Manni; Keven M Robinson; John F Alcorn
Journal:  Expert Rev Respir Med       Date:  2013-12-10       Impact factor: 3.772

9.  Distinct regulation of interleukin-17 in human T helper lymphocytes.

Authors:  Zhi Chen; Cristina M Tato; Linda Muul; Arian Laurence; John J O'Shea
Journal:  Arthritis Rheum       Date:  2007-09

10.  Differential regulation of interleukin-12 (IL-12)/IL-23 by Tim-3 drives T(H)17 cell development during hepatitis C virus infection.

Authors:  Jia M Wang; Lei Shi; Cheng J Ma; Xiao J Ji; Ruo S Ying; Xiao Y Wu; Ke S Wang; Guangyu Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.